These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15375659)

  • 1. CD117 immunoreactivity in high-grade neuroendocrine tumors of the lung: a comparative study of 39 large-cell neuroendocrine carcinomas and 27 surgically resected small-cell carcinomas.
    Pelosi G; Masullo M; Leon ME; Veronesi G; Spaggiari L; Pasini F; Sonzogni A; Iannucci A; Bresaola E; Viale G
    Virchows Arch; 2004 Nov; 445(5):449-55. PubMed ID: 15375659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kit expression in small cell carcinomas of the lung: effects of chemotherapy.
    Rossi G; Cavazza A; Marchioni A; Migaldi M; Bavieri M; Facciolongo N; Petruzzelli S; Longo L; Tamberi S; Crinò L
    Mod Pathol; 2003 Oct; 16(10):1041-7. PubMed ID: 14559988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
    Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
    Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent value of fascin immunoreactivity for predicting lymph node metastases in typical and atypical pulmonary carcinoids.
    Pelosi G; Pasini F; Fraggetta F; Pastorino U; Iannucci A; Maisonneuve P; Arrigoni G; De Manzoni G; Bresaola E; Viale G
    Lung Cancer; 2003 Nov; 42(2):203-13. PubMed ID: 14568688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promyelocytic leukemia zinc finger and histone H1.5 differentially stain low- and high-grade pulmonary neuroendocrine tumors: a pilot immunohistochemical study.
    Hechtman JF; Beasley MB; Kinoshita Y; Ko HM; Hao K; Burstein DE
    Hum Pathol; 2013 Jul; 44(7):1400-5. PubMed ID: 23416030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors.
    Brambilla E; Negoescu A; Gazzeri S; Lantuejoul S; Moro D; Brambilla C; Coll JL
    Am J Pathol; 1996 Dec; 149(6):1941-52. PubMed ID: 8952529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities.
    Swarts DR; Ramaekers FC; Speel EJ
    Biochim Biophys Acta; 2012 Dec; 1826(2):255-71. PubMed ID: 22579738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD117 immunoreactivity in stage I adenocarcinoma and squamous cell carcinoma of the lung: relevance to prognosis in a subset of adenocarcinoma patients.
    Pelosi G; Barisella M; Pasini F; Leon ME; Veronesi G; Spaggiari L; Fraggetta F; Iannucci A; Masullo M; Sonzogni A; Maffini F; Viale G
    Mod Pathol; 2004 Jun; 17(6):711-21. PubMed ID: 15073598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The spectrum of Kit (CD117) immunoreactivity in lung and pleural tumors: a study of 96 cases using a single-source antibody with a review of the literature.
    Butnor KJ; Burchette JL; Sporn TA; Hammar SP; Roggli VL
    Arch Pathol Lab Med; 2004 May; 128(5):538-43. PubMed ID: 15086281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in the expression of p53, KLF4, and p21 in neuroendocrine lung tumors.
    Naranjo Gómez JM; Bernal JF; Arranz PG; Fernández SL; Roman JJ
    Arch Pathol Lab Med; 2014 Jul; 138(7):936-42. PubMed ID: 24978920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexpression of c-kit and bcl-2 in small cell carcinoma and large cell neuroendocrine carcinoma of the lung.
    LaPoint RJ; Bourne PA; Wang HL; Xu H
    Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):401-6. PubMed ID: 18091382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
    Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
    Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased immunoreactivity of CD99 is an independent predictor of regional lymph node metastases in pulmonary carcinoid tumors.
    Pelosi G; Leon ME; Veronesi G; Spaggiari L; Pasini F; Viale G
    J Thorac Oncol; 2006 Jun; 1(5):468-77. PubMed ID: 17409901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of estrogen and progesterone receptors in primary pulmonary neuroendocrine tumors.
    Sica G; Wagner PL; Altorki N; Port J; Lee PC; Vazquez MF; Saqi A
    Arch Pathol Lab Med; 2008 Dec; 132(12):1889-95. PubMed ID: 19061285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bcl-2, p53, CD44, and CD44v6 isoform expression in neuroendocrine tumors of the lung.
    Coppola D; Clarke M; Landreneau R; Weyant RJ; Cooper D; Yousem SA
    Mod Pathol; 1996 May; 9(5):484-90. PubMed ID: 8733762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids.
    Sturm N; Rossi G; Lantuejoul S; Papotti M; Frachon S; Claraz C; Brichon PY; Brambilla C; Brambilla E
    Hum Pathol; 2002 Feb; 33(2):175-82. PubMed ID: 11957142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignancy-associated X chromosome allelic losses in foregut endocrine neoplasms: further evidence from lung tumors.
    D'Adda T; Bottarelli L; Azzoni C; Pizzi S; Bongiovanni M; Papotti M; Pelosi G; Maisonneuve P; Antonetti T; Rindi G; Bordi C
    Mod Pathol; 2005 Jun; 18(6):795-805. PubMed ID: 15578070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene product immunophenotyping of neuroendocrine lung tumors. No linking evidence between carcinoids and small-cell lung carcinomas suggested by multivariate statistical analysis.
    Sampietro G; Tomasic G; Collini P; Biganzoli E; Boracchi P; Bidoli P; Pilotti S
    Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):49-56. PubMed ID: 10937049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential distribution of the neuron-associated class III beta-tubulin in neuroendocrine lung tumors.
    Katsetos CD; Kontogeorgos G; Geddes JF; Herman MM; Tsimara-Papastamatiou H; Yu Y; Sakkas LI; Tsokos M; Patchefsky AS; Ehya H; Cooper HS; Provencio J; Spano AJ; Frankfurter A
    Arch Pathol Lab Med; 2000 Apr; 124(4):535-44. PubMed ID: 10747310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung.
    Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Iijima H; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
    Pathol Res Pract; 2008; 204(8):553-61. PubMed ID: 18440724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.